The Kennedy Institute of Rheumatology

Patent Applications and Registrations

Patent applications and USPTO patent grants for The Kennedy Institute of Rheumatology.The latest application filed is for "tnfalpha antagonists and methotrexate in the treatment of tnf-mediated disease".

Company Profile

0.4.7

The Kennedy Institute of Rheumatology -
The Kennedy Institute of Rheumatology - London GB
Kennedy Institute of Rheumatology - GB GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease App 20110123543 - Feldmann; Marc ; et al.	2011-05-26
Small molecular weight TNF receptor multimeric molecule App 20110098226 - Chernajovsky; Yuti ; et al.	2011-04-28
Methods of preventing or treating thrombosis with tumor necrosis factor antagonists Grant 7,608,262 - Elliott , et al. October 27, 2	2009-10-27
Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists App 20090263388 - Elliott; Michael J. ; et al.	2009-10-22
TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease App 20090175859 - Feldmann; Marc ; et al.	2009-07-09
Suppression of TNFalpha and IL-12 in therapy App 20070178099 - Feldmann; Marc ; et al.	2007-08-02
Treatment of tumor necrosis factor-mediated diseases App 20040228863 - Feldmann, Marc ; et al.	2004-11-18
TNF.alpha. antagonists and cyclosporin in therapy of rheumatoid arthritis Grant 6,770,279 - Feldmann , et al. August 3, 2	2004-08-03
Anti-TNF antibodies and methotrexate in the treatment of autoimmune disease App 20020136723 - Feldmann, Marc ; et al.	2002-09-26
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease Grant 6,270,766 - Feldman , et al. August 7, 2	2001-08-07
Method for treating multiple sclerosis Grant 5,958,409 - Turk , et al. September 28, 1	1999-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.